Right ventricular function and thrombus load in patients with pulmonary embolism and diagnostic delay

It has been reported that the time between symptom onset and objective diagnosis of pulmonary embolism (PE) does not affect patients' prognosis with regard to re‐thrombosis and mortality risk. However, this observation is contra‐intuitive and poorly understood. We further elaborated on this paradox by evaluating thrombus load and right ventricular function in patients with and without diagnostic delay.

[1]  P. Kamphuisen,et al.  Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism. , 2013, American journal of respiratory and critical care medicine.

[2]  Arnaud Perrier,et al.  Usefulness of preemptive anticoagulation in patients with suspected pulmonary embolism: a decision analysis. , 2012, Chest.

[3]  B. Mertens,et al.  Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome. , 2011, Chest.

[4]  Murat Topbas,et al.  The role of risk factors in delayed diagnosis of pulmonary embolism. , 2011, The American journal of emergency medicine.

[5]  J L Alonso-Martínez,et al.  Delay and misdiagnosis in sub-massive and non-massive acute pulmonary embolism. , 2010, European journal of internal medicine.

[6]  T. Morgenthaler,et al.  Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. , 2010, Chest.

[7]  A. de Roos,et al.  Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism , 2010, Thrombosis and Haemostasis.

[8]  M. Rodger,et al.  Safety of excluding acute pulmonary embolism based on an unlikely clinical probability by the Wells rule and normal D-dimer concentration: a meta-analysis. , 2010, Thrombosis research.

[9]  A. Roos,et al.  Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short‐term clinical outcome in normotensive patients suspected of having acute pulmonary embolism , 2010, Journal of thrombosis and haemostasis : JTH.

[10]  R. Yusen,et al.  Prognostic significance of delays in diagnosis of pulmonary embolism. , 2007, Thrombosis research.

[11]  R. Jensen,et al.  Delays in diagnosis of deep vein thrombosis and pulmonary embolism. , 2005, Chest.

[12]  H. Putter,et al.  Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. , 2005, Radiology.

[13]  S. Solomon,et al.  Right Ventricular Enlargement on Chest Computed Tomography: Prognostic Role in Acute Pulmonary Embolism , 2004, Circulation.

[14]  J. Dalen.  Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. , 2002, Chest.

[15]  Kenneth E Wood,et al.  Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. , 2002, Chest.

[16]  A Vieillard-Baron,et al.  New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. , 2001, AJR. American journal of roentgenology.

[17]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[18]  G. Simonneau,et al.  A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. , 1997, The New England journal of medicine.

[19]  C HISCOCK,et al.  EPIDEMICS OF TYPHOID FEVER. , 1964, Lancet.

[20]  D. W. Barritt,et al.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. , 1960, Lancet.